UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

Alimentary Pharmacology & Therapeutics (Suppl), 2017-03, Vol.45 (6), p.801-813

2017

Volltextzugriff (PDF)

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study

Alimentary Pharmacology & Therapeutics (Suppl), 2017-12, Vol.46 (11-12), p.1077-1084

2017

Volltextzugriff (PDF)

Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

Alimentary Pharmacology & Therapeutics (Suppl), 2015-04, Vol.41 (7), p.603-612

2015

Volltextzugriff (PDF)

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.1000-1008

2021

Volltextzugriff (PDF)

Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S616-S616

2019

Volltextzugriff (PDF)

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2011-09, Vol.34 (5), p.497-508

2011

Volltextzugriff (PDF)

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

Mucosal immunology, 2014-05, Vol.7 (3), p.589-601

2014

Volltextzugriff (PDF)

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score

Digestive diseases and sciences, 2016-10, Vol.61 (10), p.2986-2992

2016

Volltextzugriff (PDF)

La gastroentérite à éosinophiles

Revue française d'allergologie (2009), 2010-04, Vol.50 (3), p.248-253

2010

Volltextzugriff (PDF)

4CPS-143 Evaluation of knowledge of patients with inflammatory bowel disease treated by the reference product concerning biosimilars: role of clinical pharmacists

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A135-A136

2019

Volltextzugriff (PDF)

4CPS-144 Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A136-A136

2019

Volltextzugriff (PDF)

Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti- alpha 4 integrin therapy?

Gut, 2008-11, Vol.57 (11), p.1633-1634

2008

Volltextzugriff (PDF)

Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn’s disease patients eligible for anti-α4 integrin therapy?

Gut, 2008-11, Vol.57 (11), p.1633

2008

Volltextzugriff (PDF)

Manifestations digestives du purpura rhumatoïde

Côlon & rectum, 2008-08, Vol.2 (3), p.165-166

2008

Volltextzugriff (PDF)

P701 Quality of life of patients with inflammatory bowel diseases who live with an ostomy: Results of a French national survey

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S466-S466

2018

Volltextzugriff (PDF)

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study

Journal of Crohn's and colitis, 2021-05, Vol.15 (1), p.S486-S487

2021

Volltextzugriff (PDF)

P504 Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S486-S487

2021

Volltextzugriff (PDF)

P770 Epidemiology of inflammatory bowel diseases in French Polynesia

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S506-S506

2019

Volltextzugriff (PDF)

DOP034 Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn's disease patients treated with adalimumab for prevention of postoperative recurrence

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S47-S48

2017

Volltextzugriff (PDF)

P286 Bariatric surgery in inflammatory bowel disease: outcome and safety from a GETAID registry population

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S242-S243

2019

Volltextzugriff (PDF)

P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S579-S579

2020

Volltextzugriff (PDF)

P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S402-S403

2020

Volltextzugriff (PDF)

Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

Journal of Crohn's and colitis, 2020, Vol.14 (1)

2020

Volltextzugriff (PDF)

No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy

Journal of Crohn's and colitis, 2020, Vol.14 (1), p.S402-S403

2020

Volltextzugriff (PDF)

P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S337-S338

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(75)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study

Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn’s Disease Patients Classified i2 on the Rutgeerts Score

La gastroentérite à éosinophiles

4CPS-143 Evaluation of knowledge of patients with inflammatory bowel disease treated by the reference product concerning biosimilars: role of clinical pharmacists

4CPS-144 Establishment of a pharmaceutical standardised interview concerning biosimilars of infliximab in the daycare clinic of a gastroenterology department for patients affected by inflammatory bowel disease

Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn's disease patients eligible for anti- alpha 4 integrin therapy?

Is detection of JC virus DNA in blood a valuable screening test for progressive multifocal leukoencephalopathy in Crohn’s disease patients eligible for anti-α4 integrin therapy?

Manifestations digestives du purpura rhumatoïde

P701 Quality of life of patients with inflammatory bowel diseases who live with an ostomy: Results of a French national survey

Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study

P504 Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study

P770 Epidemiology of inflammatory bowel diseases in French Polynesia

DOP034 Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn's disease patients treated with adalimumab for prevention of postoperative recurrence

P286 Bariatric surgery in inflammatory bowel disease: outcome and safety from a GETAID registry population

P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy

Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy

P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

Suchergebnisse filtern